Table 1.
NTG |
NTG + NIMO |
NIMO |
||||
---|---|---|---|---|---|---|
Dependent variables | Baseline | 5-h average | Baseline | 5-h average | Baseline | 5-h average |
MAP (mm Hg) | 85.9 ± 3.8 | 31.6 ± 0.8* | 86.2 ± 3.7 | 32.6 ± 0.2* | 88.1 ± 3.8 | 80.0 ± 2.9 |
% change from baseline | 36.8 ± 0.9* | 37.8 ± 0.9* | 90.7 ± 3.3 | |||
PInd, % change from baseline | 100 | 30.4 ± 5.0* | 100 | 31.6 ± 0.8* | 100 | 89.8 ± 5.3 |
PbtO2 (mm Hg) | 51.7 ± 4.5 | 33.8 ± 5.2 | 38.6 ± 6.1 | 25.4 ± 2.0 | 24.3 ± 4.8 | 23.2 ± 2.3 |
% change from baseline | 65.3 ± 9.1 | 65.9 ± 5.3 | 95.2 ± 9.4 | |||
O2 saturation | 99.0 ± 0.1 | 98.2 ± 0.1 | 98.9 ± 0.2 | 97.8 ± 0.7 | 98.5 ± 0.3 | 98.7 ± 0.1 |
HR (bpm) | 463.7 ± 12.3 | 465.8 ± 7.2 | 424.0 ± 10.3 | 360.8 ± 17.9 | 431.7 ± 10.2 | 398.0 ± 8.5 |
All data are presented as mean ± sem. Change in mean arterial blood pressure (MAP) and perfusion index (PInd) is significantly larger in animals treated with nitroglycerin (NTG) or NTG + nimodipine (NIMO) than in the NIMO group (Mann-Whitney test).
PbtO2 = brain tissue oxygenation; HR = heart rate.
Statistical significance (P < 0.05).